SAREPTA THERAPEUTICS
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing. It was founded in 1980 and headquartered in Cambridge, Massachusetts.
SAREPTA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
1980-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sarepta.com
Total Employee:
501+
Status:
Active
Contact:
5417543545
Email Addresses:
[email protected]
Total Funding:
1.38 B USD
Technology used in webpage:
SPF Domain Not Resolving Amazon Microsoft Azure DNS Amazon Virginia Region DMARC Mimecast ASP.NET 2.0 Symantec.cloud EasyDNS
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Corvidia
Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-02-27 | Myonexus Therapeutics | Myonexus Therapeutics acquired by Sarepta Therapeutics | 165 M USD |
2014-07-07 | Eisai | Eisai acquired by Sarepta Therapeutics | 25 M USD |
2008-03-12 | Ercole Biotech | Ercole Biotech acquired by Sarepta Therapeutics | N/A |
Investors List
Roche Financial
Roche Financial investment in Post-IPO Equity - Sarepta Therapeutics
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Sarepta Therapeutics
MidCap Financial
MidCap Financial investment in Post-IPO Debt - Sarepta Therapeutics
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-03-16 | StrideBio | Sarepta Therapeutics investment in Series B - StrideBio | 81.5 M USD |
2020-10-22 | AavantiBio | Sarepta Therapeutics investment in Series A - AavantiBio | 107 M USD |
2018-08-09 | Lacerta Therapeutics | Sarepta Therapeutics investment in Venture Round - Lacerta Therapeutics | 30 M USD |
2018-05-08 | Myonexus Therapeutics | Sarepta Therapeutics investment in Corporate Round - Myonexus Therapeutics | 60 M USD |
Official Site Inspections
http://www.sarepta.com Semrush global rank: 1.15 M Semrush visits lastest month: 27.55 K
- Host name: ec2-54-204-43-126.compute-1.amazonaws.com
- IP address: 54.204.43.126
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149